Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach

BACKGROUND: Data monitoring of clinical trials is a tool aimed at reducing the risks of random errors (e.g. clerical errors) and systematic errors, which include misinterpretation, misunderstandings, and fabrication. Traditional ‘good clinical practice data monitoring’ with on-site monitors increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Markus Harboe, Hansen, Mathias Lühr, Safi, Sanam, Jakobsen, Janus Christian, Greisen, Gorm, Gluud, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325420/
https://www.ncbi.nlm.nih.gov/pubmed/34332547
http://dx.doi.org/10.1186/s12874-021-01344-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325420/
https://www.ncbi.nlm.nih.gov/pubmed/34332547
http://dx.doi.org/10.1186/s12874-021-01344-4

Ejemplares similares